Stay updated on RGN-259 Ophthalmic Solutions for Dry Eye Syndrome Clinical Trial
Sign up to get notified when there's something new on the RGN-259 Ophthalmic Solutions for Dry Eye Syndrome Clinical Trial page.

Latest updates to the RGN-259 Ophthalmic Solutions for Dry Eye Syndrome Clinical Trial page
- CheckyesterdayChange DetectedThe footer revision label changes from v3.7.0 to v3.7.1. The page continues to display a 403 Forbidden error.SummaryDifference0.2%

- Check8 days agoNo Change Detected
- Check15 days agoNo Change Detected
- Check22 days agoChange DetectedThe page now shows a 403 Forbidden error instead of the study record, with a minimal header/footer indicating an access restriction. This replaces the detailed trial information with an error page, affecting the core purpose of the page.SummaryDifference19%

- Check44 days agoChange DetectedARISE-3 results have been posted and the study record now includes updated inclusion/exclusion criteria. In addition, several outcomes and related data fields have been added or revised, aligning the record with the latest study documentation.SummaryDifference6%

- Check51 days agoChange DetectedIn the Study Record Dates section, several QC-related timestamp entries were removed, including 2021-11-03 and the November 2021 entries for Certification/Extension First Posted and Certification/Extension First Submitted that Met QC Criteria.SummaryDifference0.2%

- Check65 days agoChange DetectedThe page revision tag was updated from v3.6.4 to v3.6.5, indicating a new published version of the study page.SummaryDifference0.1%

- Check80 days agoChange DetectedThe page revision tag was updated from v3.6.3 to v3.6.4, indicating a new revision of the study details. The previous revision tag v3.6.3 was removed.SummaryDifference0.1%

Stay in the know with updates to RGN-259 Ophthalmic Solutions for Dry Eye Syndrome Clinical Trial
Enter your email address, and we'll notify you when there's something new on the RGN-259 Ophthalmic Solutions for Dry Eye Syndrome Clinical Trial page.